tiprankstipranks
pc:diago

Diagonal Therapeutics

Diagonal Therapeutics is a biotechnology company developing disease-modifying clustering antibodies that repair dysregulated signaling implicated in a range of genetic and severe diseases. The company combines proprietary computational and experimental techniques through its DIAGONAL Product Engine to efficiently discover and optimize therapeutic antibody assets across hematology, hepatology, and nephrology, including the DIAG723 program for HHT and PAH.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$125M
Total Amount Raised$125M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$125M
Latest Funding Amount$125M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 08, 2026
Series B
$125.00M

Related News and Analysis